This compound is primarily utilized in the pharmaceutical industry as a key intermediate in the synthesis of various active pharmaceutical ingredients (APIs). It plays a crucial role in the development of drugs targeting central nervous system disorders, particularly those related to neurotransmitter regulation. Its structural properties make it a valuable building block for creating compounds with potential therapeutic effects in treating conditions such as depression, anxiety, and other mood-related disorders. Additionally, it is used in research settings to study the pharmacological activity of chiral amines and their derivatives, aiding in the discovery of new drug candidates.